Allergic Conjunctivitis Market
Allergic Conjunctivitis Market Forecasts to 2030 - Global Analysis By Type (Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis), Age Group, Drug Type, Drug Class, Formulation, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Allergic Conjunctivitis Market is accounted for $3.2 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Allergic conjunctivitis is an inflammation of the eyes resulting from an allergic reaction to substances like pollen, dust mites, pet dander, or mold. It usually affects both eyes and has symptoms like redness, itching, watery discharge, and swelling. The condition results from the activation of histamines in the conjunctiva, which is the membrane covering the white part of the eyes, upon exposure to allergens.
According to an article in NLM, in North America, approximately 40% of the population is affected by allergic eye disease.
Market Dynamics:
Driver:
Increasing prevalence of eye allergies
The growing number of allergic eye conditions, particularly conjunctivitis, is driving demand for treatment solutions. The rising cases are linked to environmental factors like pollution, allergens, and climate change, prompting healthcare professionals to focus on effective therapies. The increasing awareness of allergic conjunctivitis among the population is also contributing to the market’s expansion as more individuals seek relief from symptoms.
Restraint:
High treatment costs
The high cost of treatments, including medications, diagnostic tests, and long-term management of allergic conjunctivitis, is a significant restraint in the market. Many patients find it challenging to access affordable care, especially in low- and middle-income regions, which limits the growth potential of the market. Additionally, healthcare disparities and inadequate insurance coverage also exacerbate the affordability challenge.
Opportunity:
Growth of online pharmacies
The rise of e-commerce, particularly the expansion of online pharmacies, presents significant growth opportunities for the allergic conjunctivitis market. Patients now have easier access to prescribed medications and over-the-counter treatments through these platforms. The convenience, competitive pricing, and doorstep delivery options contribute to increased product accessibility, which could fuel market growth.
Threat:
Competition from generic drugs
The growing availability of generic alternatives poses a threat to branded products in the allergic conjunctivitis market. Generic drugs, offering the same efficacy at lower prices, are gaining popularity, especially in price-sensitive markets. This shift threatens the market share of innovative drug developers, forcing them to adopt new strategies such as differentiating their products with added value or improving patient outcomes.
Covid-19 Impact:
The COVID-19 pandemic disrupted healthcare systems globally, impacting the diagnosis and treatment of allergic conjunctivitis. Social distancing measures, lockdowns, and the redirection of healthcare resources towards COVID-19 exacerbated the challenges in managing eye allergies. However, the increased focus on hygiene and the growing use of digital healthcare platforms helped mitigate some of these impacts, facilitating continued treatment access.
The seasonal allergic conjunctivitis segment is expected to be the largest during the forecast period
Over the estimation period, the seasonal allergic conjunctivitis segment is expected to remain the largest segment. This condition is more prevalent during specific seasons, particularly spring and autumn when pollen levels rise. As a result, a higher number of patients seek medical attention during these periods, driving demand for treatment options like antihistamines and decongestants, boosting the segment growth.
The ophthalmology clinics segment is expected to have the highest CAGR during the forecast period
Over the estimation period, the ophthalmology clinics segment is expected to experience the highest compound annual growth rate during the forecast period. The specialized services offered by these clinics, along with advanced diagnostic techniques and targeted therapies for allergic conjunctivitis, make them increasingly popular. As awareness of eye health increases, more patients are seeking specialized care, contributing to the growth of this segment.
Region with largest share:
North America is anticipated to dominate the allergic conjunctivitis market share during the forecast period. The region’s advanced healthcare infrastructure, high awareness levels, and the availability of a wide range of treatment options are key factors driving market growth. Additionally, the increasing prevalence of allergic diseases in North America contributes to the demand for conjunctivitis treatments.
Region with highest CAGR:
The Asia Pacific region is projected to register the highest CAGR in the allergic conjunctivitis market during the forecast period. This growth is attributed to the rising incidence of allergic diseases, increasing urbanization, and the expansion of healthcare access in developing countries like India and China. Additionally, the growing middle-class population and changing lifestyle factors further fuel the demand for allergy treatments in this region.
Key players in the market
Some of the key players in Allergic Conjunctivitis Market include Alcon, Allergan, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co., Ltd., Sun Pharma Advanced Research Company, Laboratoires Théa, Aciex Therapeutics, Sirion Therapeutics, Boehringer Ingelheim, Atopix Therapeutics, Laila Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Auven Therapeutics, Johnson & Johnson Vision, Sanofi, Zhaoke Ophthalmology Limited, and Oyster Point Pharma.
Key Developments:
In March 2024, Santen Pharmaceutical Co., Ltd. (hereinafter Santen) has announced that it successfully obtained manufacturing and marketing approval, for a new long-acting, trans-eyelid formulation for treating allergic conjunctivitis, “Alesion® eyelid cream 0.5%” (generic name: epinastine hydrochloride, development code: STN1011402). Alesion® eyelid cream 0.5% is a cream-type formulation to be applied to the periocular area (upper and lower eyelids) once a day. It is the world’s first cream-format treatment for allergic conjunctivitis.
In February 2021, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Pataday® Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (OTC).
Types Covered:
• Seasonal Allergic Conjunctivitis
• Perennial Allergic Conjunctivitis
• Giant Papillary Conjunctivitis
• Vernal Keratoconjunctivitis
• Atopic Keratoconjunctivitis
Age Groups Covered:
• Pediatric (Below 18 years)
• Adult (18 years and above)
Drug Types Covered:
• Prescription Drugs
• Over-the-Counter (OTC) Drugs
Drug Classes Covered:
• Antihistamine & Mast Cell Stabilizers
• Corticosteroids
• Immunomodulators
• NSAIDs
• Artificial Tears & Lubricants
Formulations Covered:
• Eye Drops
• Eye Ointments
• Oral Medications
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
End Users Covered:
• Ophthalmology Clinics
• Hospitals
• Ambulatory Surgical Centers
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Allergic Conjunctivitis Market, By Type
5.1 Introduction
5.2 Seasonal Allergic Conjunctivitis
5.3 Perennial Allergic Conjunctivitis
5.4 Giant Papillary Conjunctivitis
5.5 Vernal Keratoconjunctivitis
5.6 Atopic Keratoconjunctivitis
6 Global Allergic Conjunctivitis Market, By Age Group
6.1 Introduction
6.2 Pediatric (Below 18 years)
6.3 Adult (18 years and above)
7 Global Allergic Conjunctivitis Market, By Drug Type
7.1 Introduction
7.2 Prescription Drugs
7.3 Over-the-Counter (OTC) Drugs
8 Global Allergic Conjunctivitis Market, By Drug Class
8.1 Introduction
8.2 Antihistamine & Mast Cell Stabilizers
8.3 Corticosteroids
8.4 Immunomodulators
8.5 NSAIDs
8.6 Artificial Tears & Lubricants
9 Global Allergic Conjunctivitis Market, By Formulation
9.1 Introduction
9.2 Eye Drops
9.3 Eye Ointments
9.4 Oral Medications
10 Global Allergic Conjunctivitis Market, By Distribution Channel
10.1 Introduction
10.2 Hospital Pharmacies
10.3 Retail Pharmacies
10.4 Online Pharmacies
11 Global Allergic Conjunctivitis Market, By End User
11.1 Introduction
11.2 Ophthalmology Clinics
11.3 Hospitals
11.4 Ambulatory Surgical Centers
12 Global Allergic Conjunctivitis Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 Company Profiling
14.1 Alcon
14.2 Allergan
14.3 Bausch Health Companies Inc.
14.4 Novartis AG
14.5 Santen Pharmaceutical Co., Ltd.
14.6 Sun Pharma Advanced Research Company
14.7 Laboratoires Théa
14.8 Aciex Therapeutics
14.9 Sirion Therapeutics
14.10 Boehringer Ingelheim
14.11 Atopix Therapeutics
14.12 Laila Pharmaceuticals
14.13 Regeneron Pharmaceuticals, Inc.
14.14 Auven Therapeutics
14.15 Johnson & Johnson Vision
14.16 Sanofi
14.17 Zhaoke Ophthalmology Limited
14.18 Oyster Point Pharma
List of Tables
1 Global Allergic Conjunctivitis Market Outlook, By Region (2022-2030) ($MN)
2 Global Allergic Conjunctivitis Market Outlook, By Type (2022-2030) ($MN)
3 Global Allergic Conjunctivitis Market Outlook, By Seasonal Allergic Conjunctivitis (2022-2030) ($MN)
4 Global Allergic Conjunctivitis Market Outlook, By Perennial Allergic Conjunctivitis (2022-2030) ($MN)
5 Global Allergic Conjunctivitis Market Outlook, By Giant Papillary Conjunctivitis (2022-2030) ($MN)
6 Global Allergic Conjunctivitis Market Outlook, By Vernal Keratoconjunctivitis (2022-2030) ($MN)
7 Global Allergic Conjunctivitis Market Outlook, By Atopic Keratoconjunctivitis (2022-2030) ($MN)
8 Global Allergic Conjunctivitis Market Outlook, By Age Group (2022-2030) ($MN)
9 Global Allergic Conjunctivitis Market Outlook, By Pediatric (Below 18 years) (2022-2030) ($MN)
10 Global Allergic Conjunctivitis Market Outlook, By Adult (18 years and above) (2022-2030) ($MN)
11 Global Allergic Conjunctivitis Market Outlook, By Drug Type (2022-2030) ($MN)
12 Global Allergic Conjunctivitis Market Outlook, By Prescription Drugs (2022-2030) ($MN)
13 Global Allergic Conjunctivitis Market Outlook, By Over-the-Counter (OTC) Drugs (2022-2030) ($MN)
14 Global Allergic Conjunctivitis Market Outlook, By Drug Class (2022-2030) ($MN)
15 Global Allergic Conjunctivitis Market Outlook, By Antihistamine & Mast Cell Stabilizers (2022-2030) ($MN)
16 Global Allergic Conjunctivitis Market Outlook, By Corticosteroids (2022-2030) ($MN)
17 Global Allergic Conjunctivitis Market Outlook, By Immunomodulators (2022-2030) ($MN)
18 Global Allergic Conjunctivitis Market Outlook, By NSAIDs (2022-2030) ($MN)
19 Global Allergic Conjunctivitis Market Outlook, By Artificial Tears & Lubricants (2022-2030) ($MN)
20 Global Allergic Conjunctivitis Market Outlook, By Formulation (2022-2030) ($MN)
21 Global Allergic Conjunctivitis Market Outlook, By Eye Drops (2022-2030) ($MN)
22 Global Allergic Conjunctivitis Market Outlook, By Eye Ointments (2022-2030) ($MN)
23 Global Allergic Conjunctivitis Market Outlook, By Oral Medications (2022-2030) ($MN)
24 Global Allergic Conjunctivitis Market Outlook, By Distribution Channel (2022-2030) ($MN)
25 Global Allergic Conjunctivitis Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
26 Global Allergic Conjunctivitis Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
27 Global Allergic Conjunctivitis Market Outlook, By Online Pharmacies (2022-2030) ($MN)
28 Global Allergic Conjunctivitis Market Outlook, By End User (2022-2030) ($MN)
29 Global Allergic Conjunctivitis Market Outlook, By Ophthalmology Clinics (2022-2030) ($MN)
30 Global Allergic Conjunctivitis Market Outlook, By Hospitals (2022-2030) ($MN)
31 Global Allergic Conjunctivitis Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
